$ISRG
INTUITIVE SURGICAL INC

2013 Q1 Form 10-Q Financial Statement

#000119312513162385 Filed on April 19, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $611.4M $495.2M
YoY Change 23.47% 27.6%
Cost Of Revenue $177.1M $139.3M
YoY Change 27.14% 27.45%
Gross Profit $434.3M $355.9M
YoY Change 22.03% 27.65%
Gross Profit Margin 71.03% 71.87%
Selling, General & Admin $141.5M $124.2M
YoY Change 13.93% 25.33%
% of Gross Profit 32.58% 34.9%
Research & Development $41.60M $38.40M
YoY Change 8.33% 41.18%
% of Gross Profit 9.58% 10.79%
Depreciation & Amortization $10.40M $7.500M
YoY Change 38.67% -33.63%
% of Gross Profit 2.39% 2.11%
Operating Expenses $183.1M $162.6M
YoY Change 12.61% 24.6%
Operating Profit $251.2M $193.3M
YoY Change 29.95% 30.34%
Interest Expense $4.300M $3.800M
YoY Change 13.16% -28.3%
% of Operating Profit 1.71% 1.97%
Other Income/Expense, Net $4.300M $3.800M
YoY Change 13.16%
Pretax Income $255.5M $197.1M
YoY Change 29.63% 28.32%
Income Tax $66.60M $53.60M
% Of Pretax Income 26.07% 27.19%
Net Earnings $188.9M $143.5M
YoY Change 31.64% 37.85%
Net Earnings / Revenue 30.9% 28.98%
Basic Earnings Per Share $4.69 $3.63
Diluted Earnings Per Share $4.56 $3.50
COMMON SHARES
Basic Shares Outstanding 40.30M shares 39.50M shares
Diluted Shares Outstanding 41.40M shares 41.00M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.358B $971.0M
YoY Change 39.86% -10.92%
Cash & Equivalents $427.5M $325.9M
Short-Term Investments $931.0M $645.0M
Other Short-Term Assets $56.00M $46.00M
YoY Change 21.74% 15.0%
Inventory $135.5M $119.0M
Prepaid Expenses
Receivables $345.1M $300.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.895B $1.436B
YoY Change 31.94% -3.23%
LONG-TERM ASSETS
Property, Plant & Equipment $249.9M $210.0M
YoY Change 19.0% 28.83%
Goodwill $138.0M
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.758B $1.400B
YoY Change 25.57% 109.9%
Other Assets $96.00M $68.00M
YoY Change 41.18% 3.03%
Total Long-Term Assets $2.341B $1.897B
YoY Change 23.41% 75.0%
TOTAL ASSETS
Total Short-Term Assets $1.895B $1.436B
Total Long-Term Assets $2.341B $1.897B
Total Assets $4.236B $3.333B
YoY Change 27.09% 29.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $67.90M $50.00M
YoY Change 35.8% 16.28%
Accrued Expenses $118.0M $103.0M
YoY Change 14.56% 30.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $377.6M $314.0M
YoY Change 20.25% 24.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $86.00M $92.00M
YoY Change -6.52% 8.24%
Total Long-Term Liabilities $86.00M $92.00M
YoY Change -6.52% 8.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $377.6M $314.0M
Total Long-Term Liabilities $86.00M $92.00M
Total Liabilities $463.6M $406.0M
YoY Change 14.19% 20.47%
SHAREHOLDERS EQUITY
Retained Earnings $1.386B
YoY Change
Common Stock $2.379B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.772B $2.927B
YoY Change
Total Liabilities & Shareholders Equity $4.236B $3.333B
YoY Change 27.09% 29.79%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $188.9M $143.5M
YoY Change 31.64% 37.85%
Depreciation, Depletion And Amortization $10.40M $7.500M
YoY Change 38.67% -33.63%
Cash From Operating Activities $258.0M $165.0M
YoY Change 56.36% 56.55%
INVESTING ACTIVITIES
Capital Expenditures -$16.70M -$48.30M
YoY Change -65.42% 228.57%
Acquisitions
YoY Change
Other Investing Activities -$331.3M -$359.9M
YoY Change -7.95% -2229.59%
Cash From Investing Activities -$348.0M -$408.2M
YoY Change -14.75% -18654.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $145.7M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$35.80M 103.1M
YoY Change -134.72% 67.37%
NET CHANGE
Cash From Operating Activities $258.0M 165.0M
Cash From Investing Activities -$348.0M -408.2M
Cash From Financing Activities -$35.80M 103.1M
Net Change In Cash -$125.8M -140.1M
YoY Change -10.21% -182.8%
FREE CASH FLOW
Cash From Operating Activities $258.0M $165.0M
Capital Expenditures -$16.70M -$48.30M
Free Cash Flow $274.7M $213.3M
YoY Change 28.79% 77.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 isrg Time Limit Given To Plaintiffs For Filling Amended Complaint
TimeLimitGivenToPlaintiffsForFillingAmendedComplaint
30 D
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40161022 shares
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
100000
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
325900000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1500000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2200000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-800000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46500000
CY2013Q1 us-gaap Goodwill
Goodwill
138000000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9400000
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
51600000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1291400000
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2378500000
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4000000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2500000 shares
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
3772200000
CY2013Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3106800000
CY2013Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1757800000
CY2013Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
43800000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3116000000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66000000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
278.31
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40200000 shares
CY2013Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
92300000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1100000 shares
CY2013Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
930700000
CY2013Q1 us-gaap Liabilities
Liabilities
463600000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
67900000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1742200000
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
96600000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
9800000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
86000000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
2200000000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
192100000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1000000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
21900000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
2500000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1200000
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
6600000000
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1289800000
CY2013Q1 us-gaap Derivative Assets
DerivativeAssets
2400000
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
95600000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1385600000
CY2013Q1 us-gaap Assets
Assets
4235800000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
373.33
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
345100000
CY2013Q1 us-gaap Inventory Net
InventoryNet
135500000
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
10000000
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4235800000
CY2013Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3800000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
427500000
CY2013Q1 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
800000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
3040000000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8100000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1750400000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
377600000
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
87700000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5200000 shares
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7300000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
800000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
1894700000
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
249900000
CY2013Q1 isrg Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
7400000
CY2013Q1 isrg Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
8000000
CY2013Q1 isrg Share Based Compensation Arrangement By Share Based Payment Award Options Additional Shares Authorized Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalSharesAuthorizedWeightedAverageExercisePrice
CY2013Q1 isrg Intangible And Other Assets
IntangibleAndOtherAssets
99800000
CY2013Q1 isrg Available For Sale Securities Debt Maturities Fair Value Total
AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal
3049200000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-200000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465800000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
900000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1100000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67300000
CY2012Q4 us-gaap Goodwill
Goodwill
138100000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9300000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54300000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2240100000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4400000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
3580100000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2911500000
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1596100000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
41200000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
400000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2920500000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
104000000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40200000 shares
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
83800000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1700000 shares
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
770700000
CY2012Q4 us-gaap Liabilities
Liabilities
479100000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
57600000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
88000000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
4400000000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
20000000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
185700000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
37600000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-1000000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4600000000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
5400000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
77500000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
87000000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1333400000
CY2012Q4 us-gaap Assets
Assets
4059200000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
340.83
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
370300000
CY2012Q4 us-gaap Inventory Net
InventoryNet
121500000
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
10200000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4059200000
CY2012Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3200000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
553700000
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
1200000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6600000
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2700000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
401600000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
75900000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4800000 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6200000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1892800000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
241800000
CY2012Q4 isrg Intangible And Other Assets
IntangibleAndOtherAssets
103400000
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
1000000000
CY2013Q1 dei Trading Symbol
TradingSymbol
ISRG
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
INTUITIVE SURGICAL INC
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001035267
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15000000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
251200000
CY2013Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
12200000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
517000000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10300000
CY2013Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
194700000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
38200000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
564.21
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.56
CY2013Q1 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
7500000
CY2013Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16700000
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
300000 shares
CY2013Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
800000
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
145700000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.029 pure
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261 pure
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
258000000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-348000000
CY2013Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
900000
CY2013Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-600000
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1400000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
261.84
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-126200000
CY2013Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-38000000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
CY2013Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
89300000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationNetOfTax
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18500000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41400000 shares
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
611400000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25300000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-400000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
255500000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1500000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.69
CY2013Q1 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE 1. DESCRIPTION OF BUSINESS</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">Intuitive designs, manufactures and markets <i>da Vinci</i> Surgical Systems and related instruments and accessories, which taken together, are advanced surgical systems that the Company believes represent a new generation of surgery. The Company believes that this new generation of surgery, which the Company calls <i>da Vinci</i> surgery, combines the benefits of minimally invasive surgery (&#x201C;MIS&#x201D;) for patients with the ease of use, precision and dexterity of open surgery. A <i>da Vinci</i> Surgical System consists of a surgeon&#x2019;s console, a patient-side cart and a high performance vision system. The <i>da Vinci</i> Surgical System translates a surgeon&#x2019;s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions, or ports. The <i>da Vinci</i> Surgical System is designed to provide its operating surgeons with intuitive control, range of motion, fine tissue manipulation capability and 3-D, High-Definition (&#x201C;HD&#x201D;) vision while simultaneously allowing them to work through the small ports of MIS.</font></p> </div>
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-400000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41600000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35800000
CY2013Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
8600000
CY2013Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
200000
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
177100000
CY2013Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
300000 shares
CY2013Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
26000000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
183100000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
20600000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
30800000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40300000 shares
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15800000
CY2013Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
1200000000
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1100000 shares
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
700000 shares
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
146300000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
94400000
CY2013Q1 us-gaap Depreciation
Depreciation
10400000
CY2013Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
576000000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38200000
CY2013Q1 us-gaap Gross Profit
GrossProfit
434300000
CY2013Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
50000000
CY2013Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-9800000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9500000
CY2013Q1 us-gaap Tax Benefit From Stock Options Exercised1
TaxBenefitFromStockOptionsExercised1
19900000
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000 shares
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
188900000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4300000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
20600000
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1400000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
141500000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
700000 shares
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66600000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-400000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2013Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1100000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
190400000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5600000
CY2013Q1 isrg Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
shares
CY2013Q1 isrg Average Purchase Price Of Share Under Repurchase Program
AveragePurchasePriceOfShareUnderRepurchaseProgram
487240000
CY2013Q1 isrg Options Authorized Shares Available For Grant
OptionsAuthorizedSharesAvailableForGrant
100000 shares
CY2013Q1 isrg Number Of Individual Plaintiffs Involved In Lawsuit
NumberOfIndividualPlaintiffsInvolvedInLawsuit
26 Plaintiff
CY2013Q1 isrg Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
1900000
CY2013Q1 isrg Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
400000
CY2013Q1 isrg Unrecognized Tax Benefits Increase In Accrued Interest
UnrecognizedTaxBenefitsIncreaseInAccruedInterest
600000
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
700000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
193300000
CY2012Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
11000000
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
414400000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
500000
CY2012Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
153200000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
34400000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.50
CY2012Q1 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
8500000
CY2012Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
48300000
CY2012Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-800000
CY2012Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.043 pure
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.272 pure
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
165000000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-408200000
CY2012Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
900000
CY2012Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
300000
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1100000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-139900000
CY2012Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-25200000
CY2012Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
82900000
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationNetOfTax
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3400000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41000000 shares
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
495200000
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1600000
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
300000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
197100000
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
600000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.63
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
300000
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38400000
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103100000
CY2012Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
200000
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
139300000
CY2012Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
shares
CY2012Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
23400000
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
162600000
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
20200000
CY2012Q1 us-gaap Cost Of Services
CostOfServices
27600000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39500000 shares
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6000000
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1500000 shares
CY2012Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
111700000
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
80800000
CY2012Q1 us-gaap Depreciation
Depreciation
7500000
CY2012Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
646300000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34400000
CY2012Q1 us-gaap Gross Profit
GrossProfit
355900000
CY2012Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
133200000
CY2012Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-7000000
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1400000
CY2012Q1 us-gaap Tax Benefit From Stock Options Exercised1
TaxBenefitFromStockOptionsExercised1
20200000
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
143500000
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3800000
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
20200000
CY2012Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
500000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124200000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53600000
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
200000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
144100000
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5800000
CY2012Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1100000
CY2012Q1 isrg Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
100000
CY2012Q1 isrg Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-500000

Files In Submission

Name View Source Status
0001193125-13-162385-index-headers.html Edgar Link pending
0001193125-13-162385-index.html Edgar Link pending
0001193125-13-162385.txt Edgar Link pending
0001193125-13-162385-xbrl.zip Edgar Link pending
d508282d10q.htm Edgar Link pending
d508282dex311.htm Edgar Link pending
d508282dex312.htm Edgar Link pending
d508282dex321.htm Edgar Link pending
d508282dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
isrg-20130331.xml Edgar Link completed
isrg-20130331.xsd Edgar Link pending
isrg-20130331_cal.xml Edgar Link unprocessable
isrg-20130331_def.xml Edgar Link unprocessable
isrg-20130331_lab.xml Edgar Link unprocessable
isrg-20130331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending